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Summary
The cochlear implant (CI) is one of the most successful
neural prostheses developed to date. It offers artificial hear-
ing to individuals with profound sensorineural hearing loss
and with insufficient benefit from conventional hearing
aids. The first implants available some 30 years ago
provided a limited sensation of sound. The benefit for users
of these early systems was mostly a facilitation of lip-read-
ing based communication rather than an understanding of
speech. Considerable progress has been made since then.
Modern, multichannel implant systems feature complex
speech processing strategies, high stimulation rates and
multiple sites of stimulation in the cochlea. Equipped with
such a state-of-the-art system, the majority of recipients
today can communicate orally without visual cues and can
even use the telephone. The impact of CIs on deaf indi-
viduals and on the deaf community has thus been excep-
tional. To date, more than 300,000 patients worldwide have
received CIs. In Switzerland, the first implantation was
performed in 1977 and, as of 2012, over 2,000 systems
have been implanted with a current rate of around 150 CIs
per year. The primary purpose of this article is to provide a
contemporary overview of cochlear implantation, emphas-
ising the situation in Switzerland.
Key words: cochlear implant; deafness, neural prosthesis;
rehabilitation; severe sensorineural hearing loss; Swiss
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Introduction
Scope of the problem
Hearing loss has a significant impact on the affected indi-
vidual as well as on the society. One to two live births per
1,000 are with a permanent hearing loss, which in almost
all cases is due to reduced cochlear function. Around one-
third of these affected children have a profound hearing
loss [1]. In addition, it is estimated that around a third of the
babies born with permanent hearing loss have other neuro-
developmental conditions [2]. The prevalence of perman-
ent hearing loss in children increases with age owing to
delayed onset of genetically based hearing loss, meningitis
or late diagnosis [3]. At the other end of the age spectrum,
more than 50% of individuals over 65 years of age suffer
from some degree of hearing loss and the prevalence rises
as high as 95% among individuals aged 80 years and older
[4–6]. The World Health Organization estimates that 299
million men and 239 million women are affected by hear-
ing loss [7]. The majority suffer from mild to moderate
hearing loss and severe to profound hearing loss accounts
for less than 10% [3].
Hearing loss causes
In general, hearing loss can be split into two major categor-
ies: conductive and sensorineural. Conductive hearing loss
results from diseases of the external ear canal and middle
ear. Sensorineural hearing loss originates within the inner
ear or along the acoustic neural pathways. Aetiologies of
sensorineural hearing loss include genetic disorders, infec-
tions, ototoxicity, age or overexposure to intense sound,
among others.
Treatment options for sensorineural hearing loss
There is currently no primary treatment available for sen-
sorineural hearing loss. Only prosthetic devices can help.
Individuals with mild to moderate forms of hearing loss
can benefit from conventional hearing aids, which amplify
Figure 1
Illustration of cochlear implant components. The external parts are
shown on the left, the internal components of the implant on the
right. The scheme in the middle shows the position of the cochlear
implant components in situ.
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sound. However, the vast majority of individuals with pro-
found hearing loss or deafness are more effectively treated
with cochlear implants (CIs) than with hearing aids. As in-
dicated in figure 1, a CI directly stimulates the spiral gan-
glion neurones within the inner ear using electrical pulses,
thereby bypassing auditory hair cells. After adapting to the
new stimulation of the auditory system through the CI, the
majority of CI users are able to regain hearing and to un-
derstand speech without the need for lip-reading cues.
In the last decade, CIs have undergone impressive techno-
logical progress concerning size, microphone characterist-
ics and stimulation strategies. Along with the availability
of improved devices, indications for cochlear implantation
have been extended, partially as a result of refined surgical
techniques. Further, improved rehabilitation programmes
have been developed. Cochlear implantation offers many
more possibilities to the hearing impaired and deaf com-
pared with 10–15 years ago. The goal of the present article
is to provide an overview of the state of the art of cochlear
implantation with an emphasis on the situation in Switzer-
land. This information can be provided because of a unique
cooperative situation between Swiss CI centres. Basic in-
formation on all cochlear implantations, since the very first
surgery in 1977, is centrally stored in one database for all
five Swiss CI centres.
Cochlear implants
History of cochlear implants
The first attempts to restore hearing by electrical stimula-
tion of the auditory nerve were made in France in 1957.
Figure 2
(A) Patients implanted in Switzerland 1999–2003 and (B) Patients
implanted in Switzerland 2004–2012, divided into age groups [11].
Djourno and Eriès [8] placed a wire into the peripheral ves-
tibular system of the inner ear of a deaf patient and the
patient reported useful auditory sensations. Unfortunately,
this device failed after a short time. Although the recipient
was unable to understand speech with the device alone, it
helped lip-reading [8, 9]. In 1961 William House contin-
ued the work on single-channel intracochlear devices and
his work led to the development of the first CI approved
for adults by the USA Food and Drugs Administration in
1984 [10]. In Switzerland, the first custom-made CI was
implanted by Professor Ugo Fisch in Zürich in 1977. In
the early 1980s, multi-electrode intracochlear implants to-
gether with more efficient processing strategies were intro-
duced. The multi-channel systems had a major impact on
hearing performance and as a result cochlear implantation
became the gold-standard treatment for profound hearing
loss and deafness. By the end of 2012, more than 30,000
devices had been implanted worldwide and in Switzerland
a total of 2,237 CIs. Since 2004, around 150 cochlear im-
plantations per year were performed in Switzerland for a
population of almost 8 million inhabitants [11]. This num-
ber is comparable to around 2,000 implantations per year
for Germany with a population of 81 million. Figure 2
shows the age distribution of the patients (as percentage)
implanted in Switzerland from 1996 to 2003 and 2004 to
2012. The greatest increase over the last 7 years has been in
the under 3 and over 60 age groups. The greatest decrease
has been the age group 3 to 18 years.
Current cochlear implant designs and cochlear implant
surgery
As shown in figure 1, current CI systems can be divided
into two parts – external and internal. The externally worn
speech processor unit is equipped with a microphone,
sound and electrical stimulation processing hard- and soft-
ware, batteries and a transmitter. The implanted part con-
sists of a receiver/stimulator unit, an electrode array with
several electrode contacts for stimulation of spiral ganglion
neurones in the cochlea, and a ground electrode, which is
either integrated into the stimulator unit surface and/or is a
separate lead from the housing, depending on the CI model.
Sound (stimulation) information is processed in the speech
processor and then transmitted via radio frequency through
the intact skin to the implant receiver along with the elec-
trical energy. The implant has no internal power source. All
energy is provided by the batteries located in the speech
processor. The transmitter coil is centred over the implant
and held in place by attractive magnetic force. CI systems
from four different manufacturers are currently implanted
in Switzerland: Cochlear Ltd. (Australia), MEDEL (Aus-
tria), Advanced Bionics (Sonova, Switzerland) and Neure-
lec (France). Cochlear and MEDEL implants are the most
frequently used in Switzerland [11].
Cochlear implantation has become a highly standardised
and safe surgical procedure in the last decades. The surgery
is performed under general anaesthesia and typically lasts
around 2 hours. The surgery starts with a 5–6 cm long skin
incision behind the ear. The muscle-periosteal tissue is el-
evated to create a pocket for the receiver/stimulator unit
and a bone bed is drilled to ensure a fixed receiver location.
A cortical mastoidectomy is performed and the middle ear
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cavity close to the round window area is entered between
the facial nerve and the chorda tympany. The CI electrode
array is then inserted into the scala tympani of the coch-
lea either directly through the round window membrane or
through a nearby cochleostomy. Measurements of the elec-
trode array impedances are taken and different intraoper-
ative electrophysiological tests of the auditory nerve are
carried out to confirm correct functional operation of the
implant and provide estimates of initial speech processor
fitting values. Finally, the wound is closed. The patient usu-
ally stays 2–4 days in the hospital for the procedure. Sur-
gical complications with this procedure have become very
rare. However, some risks exist such as bleeding, infec-
tion, damage to neural structures such as the chorda tym-
pani nerve (taste sensation) and extremely rarely to the fa-
cial nerve, loss of residual hearing, vertigo and failure of
implant device [12]. The need for surgical revisions or re-
implantations of devices has become small. In Switzerland,
the overall reimplantation rate for all CIs implanted since
1977 has been 9%. Two-thirds of these cases were due to
device failure. Medical problems, accidents (head trauma)
or upgrades to newer devices accounted for the remaining
cases [11].
Sound processing in cochlear implants
The activation of spiral ganglion neurones by electrical
stimulation through cochlear implants clearly differs from
the naturally occurring stimulation of these neurones
through inner hair cells. For example, safety dictates that
the maximum stimulation amplitude in CIs is limited. This
leads to an unnaturally narrow dynamic range. The dif-
ference between acoustic threshold and maximum or un-
comfortable levels can exceed 100 dB for normal hearing.
In contrast, the difference between electrical threshold and
the maximum tolerated electrical stimulation is typically
between 5‒35 dB, depending on pulse duration and addi-
tional factors [13, 14]. This limits the ability of the device
to encode intensity differences. Another major difference
is in the resolution of frequency. The hair cell / auditory
neurone ensemble can transmit extremely small frequency
differences. In contrast, electrical stimulation is limited in
distinguishing frequency differences. Empirical informa-
tion suggests that performance improves only up to about
eight separate electrodes (channels) for electrical stimula-
tion [15, 16]. An additional difference is the lack of spon-
taneous activity in the auditory nerve after receptor hair cell
loss [15]. Modulation of spontaneous activity appears to be
an important mode of coding for acoustic stimuli, which is
lost in CI patients.
Direct stimulation of spiral ganglion neurones differs sub-
stantially from the situation in normal hearing. Therefore
coding strategies need to reflect this difference in order to
mimic normal hearing. Sound detected by the speech pro-
cessor microphones must be transformed into a set of stim-
uli that can be interpreted by the nervous system. Current
CIs feature 12 to 22 physical electrodes inserted into the
scala tympani and these electrodes plus those created vir-
tually can hardly replace the function of about 4,000 aud-
itory inner hair cells normally stimulating afferent spiral
ganglion neurones. Fast microprocessors within the speech
processor have enabled sophisticated signal processing of
sounds that are picked up by microphones. Thus, substan-
tial progress in the way the processors work has contributed
considerably to the success of modern CI systems.
To accommodate the limited dynamic range of CI stim-
ulation, the processor must compress the sound intensity
range into the stimulation electrical range before the sig-
nals are further processed for frequency content in specific
frequency bands. One of the most successful and widely
used sound processing strategies used in current CIs is
the “continuous interleaved sampling” (CIS) strategy in-
troduced by Wilson et al. in 1991 [17]. CIS is normally
used for 12 or fewer channels of stimulation. The advanced
combination encoder (ACE) strategy chooses 8 to12 out of
a number of electrodes, typically 22, to stimulate, based on
amplitude criteria [18]. For both techniques, the electric-
al amplitude modulation is set based on a non-linear re-
lationship to sound intensity within each frequency band.
The output of each band is applied to the respective elec-
trode. Simultaneous stimulation of more than one electrode
is avoided to prevent unfavourable electrical interactions.
The last stage of the mapping required in the speech pro-
cessor requires adjustment of the stimulation range to the
subjective auditory perceived thresholds and maximum
comfortable levels. These change over time, rapidly at first,
as the central nervous system accommodates to the new
signals, becoming more or less stable after 6 months. Then
other speech processor parameters (external noise reduc-
tion, direction focused microphones, etc.) can be adjusted
to satisfy the individual needs of the patient. Thus, frequent
adjustment of the speech processor parameters is required,
especially during the first 12 months after implantation.
Intraoperatively obtained electrophysiological thresholds
(stapedius reflex and neural response telemetry) can be
used to aid this fitting process.
Patients
The following paragraphs summarise the current guidelines
for cochlear implantation established by the Swiss Society
Figure 3
Speech recognition (tested at 80 dB sound pressure level) for the
Freiburg monosyllabic test in 107 unilaterally implanted adults over
2 years after implantation. The patients are divided into two groups
dependent on duration of deafness (DOD) prior to implantation [23].
Average (±1 standard deviation) monosyllabic word recognition
scores are displayed over time after first fitting in months (m) for a
group of 59 adult CI patients with a DOD <2 years (average 1.88 ±
1.24 years) and a group of 48 adult CI patients with a DOD of >5
years (16.1 ± 12 years).
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of Oto-Rhino-Laryngology, Head and Neck Surgery.
Moreover, the results presented here are derived from the
data in the Swiss cochlear implant registry if not otherwise
specified. This registry contains basic data from all five
CI centres in Switzerland (Basel, Bern, Lucerne, Geneva
and Zürich) about all CI surgeries performed in Switzer-
land since the first implantation in 1977.
Candidacy for cochlear implantation
Individuals with profound sensorineural hearing loss are
potential candidates and should be evaluated for cochlear
implantation by an experienced and specialised hospital.
The evaluation includes a thorough objective and behavi-
oural audiological assessment, imaging studies to determ-
ine the status of the inner ear and the auditory nerve, and
evaluation of additional disabilities and medical condi-
tions. Individuals with binaural hearing loss of cochlear
origin, who meet the audiological criteria for implantation
and cannot satisfactorily be fitted with conventional hear-
ing aids, qualify for surgery. Preoperative evaluation and
thorough counselling of candidates are crucial to ensure
realistic expectations and to rule out underlying conditions
potentially interfering with postoperative rehabilitation.
The critical evaluation of implant candidacy and the final
decision are typically the result of a team approach in-
volving audiologists and surgeons and, for children, pae-
diatric specialists. The goal is to enable a patient to com-
municate and understand speech better with their cochlear
implant than with previously worn hearing aids [19, 20].
With the significant technological progress of CI systems
and, thus, improving results, the guidelines for CI candid-
acy have broadened. In recent years, CIs have been im-
planted in cases with substantial residual hearing in the
low frequencies (less than 1 kHz). In these cases, so-called
hybrid or electro-acoustical stimulation systems are often
implanted. These combine the electrical cochlear stimula-
tion using a short CI electrode to restore high frequency
loss and conventional hearing aid stimulation of the resid-
ual low frequencies. Starting in 2008, CIs have also been
provided in cases of single-sided deafness and normal hear-
ing in the opposite ear. The first results demonstrate that the
Figure 4
Subjective benefits of cochlear implant users implanted until 2012
in Switzerland. Patients with first generation single channel
implants as well as patients with implant use shorter than 6 months
were excluded from this summary. Patients were asked to describe
their benefit on a five-point scale from “no benefit” to “excellent”
[11].
brain is able to effectively integrate information from the
normal hearing ear and the ear fitted with a CI [21].
Cochlear implantation in prelingually deaf children
In children with prelingual deafness the best results are ob-
served if the implantation is performed early, at best before
2 years of age. Early implanted children will enter school
with expressive and receptive spoken language skills sim-
ilar to those of children with normal hearing [22], and the
majority of these children can be enrolled in schools with
normal-hearing children. In contrast, prelingually deaf chil-
dren who receive the cochlear implant after 7 years of age
are usually unable to obtain the same levels of spoken lan-
guage skills [23]. The longer the period between the on-
set of deafness and cochlear implantation lasts, the greater
the delay of speech development. Long periods of deaf-
ness lead to morphological changes in the auditory areas of
the brain. These changes, called auditory deprivation, lim-
it congenitally deaf individuals implanted in late childhood
or adulthood from obtaining the similar benefits as indi-
viduals implanted at an early age [24].
Cochlear implantation in postlingually deaf children
and adults
The majority of postlingually deafened children and adults
are excellent candidates for cochlear implantation.
However, the time delay between onset of deafness and
cochlear implantation affects speech understanding [24,
25]. For example, a study in Bern showed that a group of
CI recipients with a short duration of deafness (<2 years)
had a substantially better speech perception outcome com-
pared to a group of recipients with a longer duration of
deafness (>3 years) (fig. 3) [26]. In cases of meningitic
deafness, progressive fibrotic changes in the cochlea mean
that the earliest possible (bilateral) implantation is the best
way to ensure a smooth complete insertion of the implant
electrode and a satisfactory outcome [27, 28]. There is
no age limit for cochlear implantation. Implantation has
been performed in patients older than 80 years. However,
the biological age in the context of general health, fitness
for surgery, intellectual capacity and communication skills
need to be considered in the CI decision process.
Bilateral cochlear implantation
Bilateral CIs offer improved hearing results compared with
a unilateral CI in most of bilaterally deaf implantees. Hear-
ing with two ears or two CIs is associated with better
speech perception in noise and improved localisation of
sound sources [29]. Also in quiet, an improved speech per-
ception has been observed. On average, 10% more mono-
syllabic words are understood in the bilateral compared
with the unilateral listening situation [30]. Bilateral coch-
lear implantation can be performed simultaneously in a
single operation or sequentially in two separate procedures.
In the case of sequential implantation, the time interval
between the two implantations should be as short as pos-
sible and ideally not exceed 1 year. In Switzerland, early
bilateral implantation is a standard treatment for deaf chil-
dren; however, some differences regarding the timing of
surgery (sequential vs simultaneous implantation) can be
found across the five CI centres. For this reason, among
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those children implanted over the past 10 years in Switzer-
land with an implant in the contralateral ear within 5 years
of the first implant, 47.8% out of a total of 159 implants
(status December 2012) received the second implant within
3 months and 34.6% simultaneously with the first oper-
ation. This resulted in a relative uniform distribution of
second (bilateral) implantation times over the 5 years.
Rehabilitation after cochlear implantation
Although CIs can restore speech understanding to a high
level, they cannot provide normal hearing. Sound is per-
ceived differently with CIs. In contrast to normal hearing or
hearing with conventional hearing aids, the auditory nerve
is stimulated electrically and the interpretation of this new
perception needs to be trained thoroughly, a process that
may require several months to years. Therefore, follow-up
care and guided rehabilitation is essential for recipients of
CIs to ensure the best achievable outcome. The speech pro-
cessors are typically fitted for the first time around 3–6
weeks after surgery. In the following months, there is a
steep learning curve in auditory performance, which typic-
ally reaches a plateau after 1–2 years (fig. 3) [31].
More than 70% of the patients implanted in Switzerland
describe their benefit as excellent or good [11] (fig. 4).
This reflects the performance in audiological testing. More
than half of the tested adults reach over 50% word recog-
nition in the Freiburger monosyllabic test [11]. In children,
more than 80% reach word discrimination scores between
80%–100% in the Monosyllabic-Trochee-Polysyllabic-
Word Test and 82% score between 60%–100% in the
MAIS-Test (Meaningful Auditory Integration Scale) [11].
Safety issues
Although the occurrence of bacterial meningitis has been
reported following cochlear implantation, this medical
complication is extremely rare. Nevertheless, all CI can-
didates need to be counselled about this rare complication,
and vaccination against the most prevalent causal organ-
ism, Streptococcus pneumoniae, should be recommended
to the patient [32].
Special caution is warranted if a CI user should undergo
magnetic resonance imaging (MRI). If feasible, computed
tomography (CT) should be used. If CT is not considered
adequate, the CI manufacturer’s guidelines regarding MRI
investigations need to be followed carefully. Even if an
MRI is technically possible when the CI manufacturer’s
guidelines are followed (use of 1.5 Tesla scanner, removal
of speech processor, head bandaging to hold the implant
securely) warranty issues may limit MRI investigations in
some radiology institutions. Consultation with the manu-
facturer concerning specific recommendations according to
the type of CI or at least a review of the company’s website
is strongly recommended before performing MRI.
Electrosurgical instruments are capable of inducing cur-
rents that can harm the CI electronics. Therefore, monopo-
lar electrosurgical instruments cannot be used in patients
with a cochlear implant. However, bipolar electrosurgical
instruments may be used. The cautery electrodes must not
contact the implant.
Future trends in cochlear implantation
Despite the outstanding success of cochlear implants, new
innovations are possible as indicated below.
Cochlear implantation for single-sided deafness
Recent publications [21, 33, 34] indicate that patients can
benefit from a CI in an ear with profound hearing loss
even if normal hearing is present in the opposite ear. These
patients show a significantly higher speech perception in
background noise and improved localisation ability com-
pared with users of conventional CROS (contralateral rout-
ing of signal) hearing aids, BAHA (bone-anchored hearing
aid) CROS or untreated patients. CROS hearing aids and
BAHA simply bypass the deaf ear by routing the signals
from the deaf side to the contralateral normal-hearing ear.
In contrast, a CI stimulates the spiral ganglion neurones on
the deaf side, thereby adding a second hearing ear to the
brain. A multicentre study in Switzerland is currently aim-
ing to further clarify the benefits of cochlear implantation
for patients with single-sided deafness.
Fully implantable cochlear implant systems
Fully implantable cochlear implants would be a significant
improvement in terms of comfort and cosmetics. However,
the main challenge in developing such an implant consists
of creating a subcutaneous microphone which is not dom-
inated by internal body noise. At the moment there is no
approved fully implantable cochlear implant system avail-
able, but prototypes have been implanted in clinical trials
outside of Switzerland [35].
Improving cochlear implant performance in the future
The number of effective channels used in CIs is limited
through overlapping electrical fields, which are a conse-
quence of the anatomical distance between the stimulating
electrodes and the spiral ganglion neurones in the cochlea.
A gapless interface between the electrodes and the neur-
ones could substantially reduce channel interaction and
thereby allow a substantial increase in the number of inde-
pendent channels. One way to achieve this goal would be to
attract the peripheral processes of the spiral ganglion neur-
ones towards the electrodes using growth factors released
from the implant surface. If successful, such an approach
may substantially improve the quality of hearing with CIs
in the future [37].
Another way to increase the number of effective channels
would be to change the mode of electrical stimulation so
that the overlap of electrical fields is reduced. At present,
monopolar stimulation is mostly used where one intracoch-
lear electrode is stimulated versus a remote reference elec-
trode. Using simultaneously more than one intracochlear
electrode with various phase and amplitude values, so
called bipolar, tripolar, quadrupolar or phase array config-
urations, may help to reduce current spread.
Conclusions
Cochlear implants have become highly successful neuro-
prosthetic devices in the last 20 years. In Switzerland, over
2000 CIs have been implanted since the first implantation
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in 1977. Current CI systems can effectively restore hearing
in the majority of deaf individuals to a degree that speech
can be understood, even on the telephone and without the
help of visual cues. Thus, the impact on the patient’s qual-
ity of life has been exceptional. The surgical procedure can
be regarded as being safe and standardized with minimum
associated risks. Despite this success, limitations remain,
leaving room for research developments to further improve
future cochlear implants.
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Figures (large format)
Figure 1
Illustration of cochlear implant components. The external parts are shown on the left, the internal components of the implant on the right. The
scheme in the middle shows the position of the cochlear implant components in situ.
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Figure 2
(A) Patients implanted in Switzerland 1999–2003 and (B) Patients implanted in Switzerland 2004–2012, divided into age groups [11].
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Figure 3
Speech recognition (tested at 80 dB sound pressure level) for the Freiburg monosyllabic test in 107 unilaterally implanted adults over 2 years
after implantation. The patients are divided into two groups dependent on duration of deafness (DOD) prior to implantation [23]. Average (±1
standard deviation) monosyllabic word recognition scores are displayed over time after first fitting in months (m) for a group of 59 adult CI
patients with a DOD <2 years (average 1.88 ± 1.24 years) and a group of 48 adult CI patients with a DOD of >5 years (16.1 ± 12 years).
Figure 4
Subjective benefits of cochlear implant users implanted until 2012 in Switzerland. Patients with first generation single channel implants as well
as patients with implant use shorter than 6 months were excluded from this summary. Patients were asked to describe their benefit on a five-
point scale from “no benefit” to “excellent” [11].
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